23078780|t|Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator.
23078780|a|BACKGROUND: More than 50% of patients undergoing lifelong suppressive antiviral treatment for HIV-1 infection develop minor HIV-1-associated neurocognitive disorders. Neurological complications during HIV-1 infection are the result of direct neuronal damage by proinflammatory products released from HIV-1-infected or -uninfected activated lymphocytes, monocytes, macrophages, microglia and astrocytes. The specific pro-inflammatory products and their roles in neurotoxicity are far from clear. We investigated proinflammatory cytokines and chemokines in the cerebrospinal fluid (CSF) of HIV-demented (HIV-D) and HIV-nondemented (HIV-ND) patients and studied their affect on neuroglial toxicity. METHODS AND RESULTS: Bioplex array showed elevated levels of signatory chemokines or cytokines (IL-6, IFN-gamma, CXCL10, MCP-1 and PDGF) in the CSF of HIV-D patients (n = 7) but not in that of HIV-ND patients (n = 7). Among the signatory cytokines and chemokines, CXCL10 was distinctly upregulated in-vitro in HIV-1 (NLENG1)-activated human fetal astrocytes, HIV-1 (Ba-L)-infected macrophages, and HIV-1 (NLENG1)-infected lymphocytes. Virus-infected macrophages also had increased levels of TNF-alpha. Consistently, human fetal astrocytes treated with HIV-1 and TNF-alpha induced the signatory molecules. CXCL10 in combination with HIV-1 synergistically enhanced neuronal toxicity and showed chemotactic activity (~ 40 fold) for activated peripheral blood mononuclear cells (PBMC), suggesting the intersection of signaling events imparted by HIV-1 and CXCL10 after binding to their respective surface receptors, CXCR4 and CXCR3, on neurons. Blocking CXCR3 and its downstream MAP kinase (MAPK) signaling pathway suppressed combined CXCL10 and HIV-1-induced neurotoxicity. Bryostatin, a PKC modulator and suppressor of CXCR4, conferred neuroprotection against combined insult with HIV-1 and CXCL10. Bryostatin also suppressed HIV-1 and CXCL10-induced PBMC chemotaxis. Although, therapeutic targeting of chemokines in brain may have adverse consequences on the host, current findings and earlier evidence suggest that CXCL10 could strongly impede neuroinflammation. CONCLUSION: We have demonstrated induction of CXCL10 and other chemokines/cytokines during HIV-1 infection in the brain, as well as synergism of CXCL10 with HIV-1 in neuronal toxicity, which was dampened by bryostatin.
23078780	15	25	neurotoxic	Disease	MESH:D020258
23078780	35	42	CXCL-10	Gene	3627
23078780	46	51	HIV-1	Species	11676
23078780	63	71	dementia	Disease	MESH:D003704
23078780	87	94	CXCL-10	Gene	3627
23078780	103	123	neuro-glial toxicity	Disease	MESH:D004194
23078780	136	139	PKC	Gene	112476
23078780	180	188	patients	Species	9606
23078780	245	260	HIV-1 infection	Disease	MESH:D015658
23078780	275	280	HIV-1	Species	11676
23078780	292	316	neurocognitive disorders	Disease	MESH:D019965
23078780	318	344	Neurological complications	Disease	MESH:D002493
23078780	352	367	HIV-1 infection	Disease	MESH:D015658
23078780	393	408	neuronal damage	Disease	MESH:D009410
23078780	451	456	HIV-1	Species	11676
23078780	571	583	inflammatory	Disease	MESH:D007249
23078780	612	625	neurotoxicity	Disease	MESH:D020258
23078780	739	751	HIV-demented	Disease	MESH:D015658
23078780	753	758	HIV-D	Disease	MESH:D015658
23078780	764	768	HIV-	Disease	MESH:D015658
23078780	789	797	patients	Species	9606
23078780	826	845	neuroglial toxicity	Disease	MESH:D064420
23078780	943	947	IL-6	Gene	3569
23078780	949	958	IFN-gamma	Gene	3458
23078780	960	966	CXCL10	Gene	3627
23078780	968	973	MCP-1	Gene	6347
23078780	998	1003	HIV-D	Disease	MESH:D015658
23078780	1004	1012	patients	Species	9606
23078780	1047	1055	patients	Species	9606
23078780	1111	1117	CXCL10	Gene	3627
23078780	1157	1162	HIV-1	Species	11676
23078780	1182	1187	human	Species	9606
23078780	1206	1211	HIV-1	Species	11676
23078780	1213	1217	Ba-L	CellLine	CVCL:B0JD
23078780	1245	1250	HIV-1	Species	11676
23078780	1338	1347	TNF-alpha	Gene	7124
23078780	1363	1368	human	Species	9606
23078780	1399	1404	HIV-1	Species	11676
23078780	1409	1418	TNF-alpha	Gene	7124
23078780	1452	1458	CXCL10	Gene	3627
23078780	1479	1484	HIV-1	Species	11676
23078780	1510	1527	neuronal toxicity	Disease	MESH:D009410
23078780	1689	1694	HIV-1	Species	11676
23078780	1699	1705	CXCL10	Gene	3627
23078780	1759	1764	CXCR4	Gene	7852
23078780	1769	1774	CXCR3	Gene	2833
23078780	1797	1802	CXCR3	Gene	2833
23078780	1878	1884	CXCL10	Gene	3627
23078780	1889	1894	HIV-1	Species	11676
23078780	1903	1916	neurotoxicity	Disease	MESH:D020258
23078780	1918	1928	Bryostatin	Chemical	MESH:D054713
23078780	1932	1935	PKC	Gene	112476
23078780	1964	1969	CXCR4	Gene	7852
23078780	2026	2031	HIV-1	Species	11676
23078780	2036	2042	CXCL10	Gene	3627
23078780	2044	2054	Bryostatin	Chemical	MESH:D054713
23078780	2071	2076	HIV-1	Species	11676
23078780	2081	2087	CXCL10	Gene	3627
23078780	2262	2268	CXCL10	Gene	3627
23078780	2291	2308	neuroinflammation	Disease	MESH:D000090862
23078780	2356	2362	CXCL10	Gene	3627
23078780	2373	2383	chemokines	Gene	
23078780	2384	2393	cytokines	Gene	
23078780	2401	2416	HIV-1 infection	Species	
23078780	2455	2461	CXCL10	Gene	3627
23078780	2467	2472	HIV-1	Species	11676
23078780	2476	2493	neuronal toxicity	Disease	MESH:D009410
23078780	2517	2527	bryostatin	Chemical	MESH:D054713
23078780	Association	MESH:D003704	3627
23078780	Association	MESH:D054713	112476
23078780	Association	MESH:D020258	3627
23078780	Positive_Correlation	MESH:D009410	3627
23078780	Positive_Correlation	MESH:D015658	3569
23078780	Association	MESH:D004194	112476
23078780	Association	3627	7852
23078780	Association	2833	3627
23078780	Positive_Correlation	MESH:D015658	3627
23078780	Positive_Correlation	MESH:D015658	6347
23078780	Association	MESH:D020258	2833
23078780	Positive_Correlation	MESH:D004194	3627
23078780	Negative_Correlation	MESH:D054713	7852
23078780	Positive_Correlation	MESH:D015658	3458

